During Analytica 2024 in Munich, Germany, Michael Lämmerhofer of the University of Tuebingen discusses the potential of chiral stationary phases (CSPs) in different applications.
Michael Lämmerhofer is a full professor (W3) for pharmaceutical (bio-)analysis at the University of Tübingen, Germany. H earned his PhD in Pharmaceutical Chemistry at the University of Graz, Austria. He was coworker of Professor W. Lindner (University of Vienna, Austria) until 2011 and from 1999 to 2000 he was post-doc at the Department of Chemistry of the University of California, Berkeley, USA, with Prof Frantisek Svec.
His research interests include the development of functionalized separation materials (chiral stationary phases, mixed‑mode phases, chemo- and bioaffinity materials, nanoparticles, monoliths), metabolomics and lipidomics, pharmaceutical analysis (impurity profiling, enantioselective analytics), multidimensional separations, and biopharmaceuticals analysis.
In this interview segment, Lämmerhofer discusses the following questions:
To learn more about Analytica 2024, you can watch more of our team's videos from the festival, where we interview people like Elia Psillakis of Technical University of Crete and Anne Bendt of the Singapore Lipidomics Incubator (SLING).
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.
Characterization of Product Related Variants in Therapeutic Monoclonal Antibodies
July 16th 2024Navin Rauniyar and Xuemei Han of Tanvex Biopharma USA recently discussed how identifying product-related variants through characterization enables the recognition of impurities that compromise the quality and safety of drugs.